Clinical trial
A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke…
NCT00044070 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00044070 |
|---|---|
| Title | A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Effects of YM872 on Lesion Volume as Measured by Diffusion, Perfusion, and FLAIR Magnetic Resonance Imaging in Patients With Acute Ischemic Stroke |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident |
| Intervention type | Drug |
| Interventions | YM872 (zonampanel) |
| Start date | Dec 1, 2000 |
| Completion | Jan 1, 2003 |
| First posted | Aug 20, 2002 |
| Last update posted | Apr 3, 2006 |
| Countries | Austria, Belgium, Canada, Germany, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: